scispace - formally typeset
M

Monica H. Wojcik

Researcher at Boston Children's Hospital

Publications -  84
Citations -  1263

Monica H. Wojcik is an academic researcher from Boston Children's Hospital. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 13, co-authored 45 publications receiving 633 citations. Previous affiliations of Monica H. Wojcik include Harvard University & Broad Institute.

Papers
More filters
Journal ArticleDOI

High Rate of Recurrent De Novo Mutations in Developmental and Epileptic Encephalopathies

Fadi F. Hamdan, +119 more
TL;DR: De novo missense variants explained a larger proportion of individuals in the series than in other series that were primarily ascertained because of ID, indicating that the genetic landscape of DEE might be different from that of ID without epilepsy.
Journal ArticleDOI

Monogenic variants in dystonia: an exome-wide sequencing study.

Michael Zech, +120 more
- 01 Nov 2020 - 
TL;DR: The role of monogenic variants across the range of dystonic disorders is determined, providing guidance for the introduction of personalised care strategies and fostering follow-up pathophysiological explorations.
Journal ArticleDOI

Prospective, phenotype-driven selection of critically ill neonates for rapid exome sequencing is associated with high diagnostic yield.

TL;DR: Phenotype-based patient selection is effective at identifying critically ill neonates with a high likelihood of receiving a molecular diagnosis via rapid-turnaround exome sequencing, leading to faster and more accurate diagnoses, reducing unnecessary testing and procedures, and informing medical care.
Journal ArticleDOI

Histone H3.3 beyond cancer: Germline mutations in Histone 3 Family 3A and 3B cause a previously unidentified neurodegenerative disorder in 46 patients

Laura M Bryant, +146 more
- 02 Dec 2020 - 
TL;DR: Patient histone posttranslational modifications (PTMs) analysis revealed notably aberrant local PTM patterns distinct from the somatic lysine mutations that cause global PTM dysregulation, suggesting that the mechanism of germline mutations are distinct from cancer-associated somatic histone mutations but may converge on control of cell proliferation.